Demo
LFVN Nasdaq· LifeVantage Corporation
FundamentalsNews digest Peer analysis
Login
LFVN Nasdaq· LifeVantage Corporation
Earnings report Q4 2023

LifeVantage Reports Decline in Revenue for the Latest Quarter

Segments of revenue

LifeVantage Corporation generated net revenue of $51.6 million in the latest quarter, a decrease from $53.7 million in the same quarter of the previous year. For the six months ended December 31, 2023, the company's net revenue was $103.0 million, compared to $105.4 million in the same period of the prior year. The Americas region accounted for $36.0 million of the total revenue, representing a decrease of 9.5% compared to the previous year. The Asia/Pacific & Europe region contributed $15.6 million in revenue, reflecting a decline of 18.2% compared to the prior year.

Strengths

Despite the decline in revenue, LifeVantage Corporation highlighted that foreign currency fluctuations negatively impacted revenue by $0.2 million during the latest quarter. The company also mentioned that revenue in Japan increased by 3.9% on a constant currency basis for the quarter, driven by higher average revenue per account and the introduction of TrueScienceLiquid Collagen, which generated approximately $1.8 million in revenue during the quarter.

Challenges

The decline in revenue for the latest quarter is a notable weakness for LifeVantage Corporation. The decrease in revenue from the Americas and Asia/Pacific & Europe regions indicates challenges in these markets. Additionally, the company reported a net loss of $656,000 for the quarter, compared to a net loss of $1.1 million in the same quarter of the previous year.

Noteworthy

It is worth mentioning that LifeVantage Corporation experienced a decrease in the number of active accounts, with a decline of 12.1% compared to the prior year. This decline in active accounts may have contributed to the decrease in revenue for the latest quarter.

Summary

LifeVantage Corporation reported a decline in revenue for the latest quarter, with net revenue of $51.6 million. The decrease in revenue was primarily driven by lower revenue from the Americas and Asia/Pacific & Europe regions. However, the company highlighted that foreign currency fluctuations and the introduction of TrueScienceLiquid Collagen in Japan had an impact on revenue. LifeVantage Corporation also reported a net loss for the quarter and a decline in the number of active accounts. These factors indicate challenges that the company may need to address in order to improve its financial performance.

Source documents

Form 10-Q  filed on Jan 30, 2024
86 pages scanned

Reference data

Company financials Q4 revenue 51.6M
Analyst estimates Q4 EPS beat by ∞%
Sign up to Fey

Get in-depth analysis on thousands of stocks for just $30/month. Cancel anytime.